Incorporate a Company in a Respectable European Jurisdiction: Welcome to Madeira!

This post is devoted to Madeira, a Portuguese island where there is a free trade zone that attracts entrepreneurs from all over the world. This is a great place for company incorporation if you want to combine a well-reputed European jurisdiction and benefits typical of the best tax havens available. And if you are interested in a European residence permit, you will be able to easily get one if you register a company in Madeira as Portugal offers a program for those who wish to live there (and it leads to permanent residence and citizenship by naturalization within no more than 10 years).

Looks interesting? We would like to invite you to our portal where you will find other offers like this (just to compare). Our experts help people set up companies on a regular basis and they know all the ins and outs.

Madeira Free Zone: Overview

Madeira, Portugal, is a jurisdiction that set up an International Business Center (IBCM) to attract foreign businesses by offering special tax benefits to them. The company incorporated in Madeira Free Zone will only pay 5% on its profits. For comparison, if it is based in Madeira, the tax rate equals 14.7%, and companies that make their profits in Portugal will be liable for 21%.

Madeira Company: Special Features

Let’s look at the benefits and limitations of company registration in Madeira.

Limitations for Certain Companies

There are some businesses that have no right to obtain tax discounts even if they are registered in the Madeira free trade zone:

  • Insurance companies
  • Financial institutions (banks, and so on)
  • Entrepreneurs that deal with cryptocurrencies and similar risky activities.

You can incorporate this kind of company in Portugal if you want to, but you will need special permission and you will have to comply with different tax rules.

Exemption from Taxes on Dividends and Capital Gains

If you want to benefit from zero tax rates on dividends and capital gains, your offshore company will have to fulfill certain requirements:

  • They are required to hold at least 10% shares in a Madeira IBC for no less than 12 months.
  • The subsidiary company needs to pay 60% of the tax rates applicable in Portugal.
  • The subsidiary company cannot be a resident of any jurisdiction that is on the blacklist.

Manufacturing and Warehouse Companies

These companies can pay taxes at lower rates set in the Madeira Free Trade Zone and get a 50% tax reduction if they comply with some of the criteria below:

  • They add value to the Portuguese economy by introducing tech advancements, new products, and so on.
  • They expand the kinds of business activities to add variety to Madeira’s local economy.
  • They actively employ qualified specialists to make the region more economically prosperous.
  • They make important improvements to the environment.
  • They create at least 15 jobs within 5 years.

In addition, the above companies can use a suspension mechanism, which means that import duties are only levied if the goods are transported outside the Madeira Free Trade Zone’s boundaries.

Tax Advantages for Shareholders

If you are a non-resident investor (an individual or a legal entity) who holds shares in Limited Liability Companies, you will not have to pay withholding taxes on the dividends received from businesses in Madeira. If you want to be eligible for these benefits, you should not be a resident of countries that are on Portugal’s blacklist, and you are required to own no less than 10% of shares for at least 1 year.

Tax Benefits for Madeira IBCs

Madeira IBCs enjoy some benefits in addition to those discussed above:

  • 80% discount on the stamp duty if the involved parties are not residents of Portugal.
  • 80% reduction on property taxes, property transfer taxes, and others.

Company Incorporation: General Requirements

Here are the conditions you will need to fulfill to successfully register a company:

  • Your company needs at least 1 shareholder (a resident of any country)
  • You will need a local office to keep the company documents.
  • You will need to hire at least one director who can be a tax resident of any country.
  • Company financial reports have to be submitted on an annual basis.
  • Annual general meetings of shareholders can be held online.
  • Audits are not required.


If you want to form a company in Madeira’s Free Trade Zone, we can do it for you within 15 business days. Please click on the above link to get in touch with our expert and discuss all the important issues.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“The completion of the APEX-AV Study represents an important milestone in the catheter-directed therapies CDT space for the treatment of pulmonary embolism. I sincerely thank all the investigators for their commitment and dedication,” said William Brent Keeling, MD, Associate Professor of Surgery, Department of Surgery, at the Emory University School of Medicine, and Immediate Past President, The PERT Consortium™.
The combined expertise of Cordance Medical and the Airan and Williams Labs will see NeuroAccess utilized to deliver a novel application of drug-loaded nanoparticles, providing targeted drug delivery to the brain.
Medixine prepares for 2024 with two key senior hires, VP of Operations in the U.S. and VP of Engineering in Finland. The appointments will enhance support and service to the company’s U.S.-based partners, including leading respiratory homecare provider Lincare and a major medical device manufacturer. In addition, the new hires will enable streamlined design, testing, and deployment of new product features for more patient-centric, cost and time-effective treatment of chronic conditions.
Innovent Biologics and Synaffix: Under the terms of the expanded agreement, Innovent will be responsible for the research, development, manufacturing and commercialization of new ADC candidates. Synaffix is eligible to receive an upfront payment plus potentialmilestone payments and royalties on commercial sales for each licensed target.
Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.

By using this website you agree to accept Medical Device News Magazine Privacy Policy